Skip to main content
. 2019 Jun 4;22(2):177–183. doi: 10.4103/aja.aja_38_19

Figure 2.

Figure 2

Decision curve analyses comparing the added benefit of ALP, NLR, or fibrinogen in addition to standard pathologic characteristics for the outcomes of (a) CSS, (b) RFS, and (c) OS. ALP: alkaline phosphatase; NLR: neutrophil-to-lymphocyte ratio; CSS: cancer-specific survival; RFS: disease recurrence-free survival; OS: overall survival.